Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | CES2 | O00748 | 3/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.55 |
| ▸ | STAT3 | P40763 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | TAS2R46 | P59540 | 4/20 | 0.33 |
| ▸ | TAS2R31 | P59538 | 2/20 | 0.33 |
| ▸ | TAS2R10 | Q9NYW0 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alpha-Terpineol SCHEMBL10925321 | 1.00 | LMNA (1.00) | LMNACES2CYP3A4ALOX15STAT3 | |
| Alpha-Terpineol SCHEMBL891812 | 1.00 | LMNA (1.00) | LMNACES2CYP3A4ALOX15STAT3 | |
| Alpha-Terpineol SCHEMBL980991 | 1.00 | LMNA (1.00) | LMNACES2CYP3A4ALOX15STAT3 | |
| Alpha-Terpineol SCHEMBL28466 | 1.00 | LMNA (1.00) | LMNACES2CYP3A4ALOX15STAT3 | |
| Alpha-Terpineol SCHEMBL9562893 | 0.98 | LMNA (0.96) | LMNACES2CYP3A4ALOX15STAT3 | |
| Nephthenol SCHEMBL14828377 | 0.93 | LMNA (0.86) | LMNACES2CYP3A4ALOX15STAT3 | |
| Alpha-Terpineol SCHEMBL9706032 | 0.93 | LMNA (0.86) | LMNACES2CYP3A4ALOX15STAT3 | |
| Alpha-Terpineol SCHEMBL11682479 | 0.89 | LMNA (0.80) | LMNACES2CYP3A4ALOX15STAT3 | |
| Alpha-Terpineol SCHEMBL8146925 | 0.85 | LMNA (0.73) | LMNACES2CYP3A4ALOX15STAT3 | |
| SCHEMBL5708608 | 0.83 | LMNA (0.71) | LMNACES2CYP3A4ALOX15STAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0565159-B1 | 8-Hydroxycymene preparation by dehydrogenation | QUEST INT (NL) | 1996-08-14 | — | — | EP | claimed |
| EP-0417825-B1 | Cymenol preparation by direct dehydrogenation | QUEST INT (NL) | 1993-10-27 | — | — | EP | claimed |
| CN-117651500-A | Vaporizable material for aerosol generating devices | 日本烟草国际股份有限公司 | 2024-03-05 | — | — | CN | disclosed |
| WO-2019034614-A1 | PSEUDOTSUGA MENZIESII EXTRACT, METHOD FOR OBTAINING SAME AND USE THEREOF | CENTRE DE VALORISATION AGRO RESSOURCES (FR) | 2019-02-21 | — | — | WO | disclosed |
| EP-3307393-A1 | FRAGRANCE COMPOSITION | The Procter and Gamble Company (US) | 2018-04-18 | — | — | EP | disclosed |
| EP-3307231-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | The Procter and Gamble Company (US) | 2018-04-18 | — | — | EP | disclosed |
| EP-3307394-A1 | FRAGRANCE FIXATIVES AND COMPOSITIONS COMPRISING THEREOF | The Procter and Gamble Company (US) | 2018-04-18 | — | — | EP | disclosed |
| WO-2016205301-A1 | FRAGRANCE FIXATIVES AND COMPOSITIONS COMPRISING THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2016-12-22 | — | — | WO | disclosed |
| WO-2016200759-A1 | FRAGRANCE COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2016-12-15 | — | — | WO | disclosed |
| WO-2016200761-A2 | FRAGRANCE COMPOSITIONS AND USES THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2016-12-15 | — | — | WO | disclosed |
| WO-2016200760-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2016-12-15 | — | — | WO | disclosed |
| US-20140350121-A1 | ANTIMICROBIAL COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC | 2014-11-27 | — | — | US | disclosed |
| EP-2621462-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | The Procter and Gamble Company (US) | 2013-08-07 | — | — | EP | disclosed |
| WO-2012044728-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | THE PROCTER & GAMBLE COMPANY (US) | 2012-04-05 | — | — | WO | disclosed |
| WO-2011127011-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2011-10-13 | — | — | WO | disclosed |
| WO-2011127030-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2011-10-13 | — | — | WO | disclosed |
| WO-2010117740-A2 | ENHANCED FORMULATIONS, COMPOSITIONS AND METHODS FOR PEST CONTROL | TYRATECH, INC. (US) | 2010-10-14 | — | — | WO | disclosed |
| WO-2010115065-A2 | METHODS FOR PEST CONTROL EMPLOYING MICROEMULSION-BASED ENHANCED PEST CONTROL FORMULATIONS | TYRATECH, INC. (US) | 2010-10-07 | — | — | WO | disclosed |
| WO-2009117621-A1 | PEST CONTROL COMPOSITIONS AND METHODS | TYRATECH, INC. (US) | 2009-09-24 | — | — | WO | disclosed |
| WO-2007038524-A2 | COCRYSTALLIZATION METHODS | SSCI, INC. (US) | 2007-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140350121-A1 | ANTIMICROBIAL COMPOSITION | TAS2R40, TAS2R39, POLR1C | LMNA 3949/4885CES2 2400/4885CYP3A4 1596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.